Nuveen Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-45,865
| Closed | -$1.94M | – | 3454 |
|
2024
Q1 | $1.94M | Buy |
45,865
+11,320
| +33% | +$479K | ﹤0.01% | 2419 |
|
2023
Q4 | $1.44M | Buy |
34,545
+12,942
| +60% | +$541K | ﹤0.01% | 2566 |
|
2023
Q3 | $815K | Hold |
21,603
| – | – | ﹤0.01% | 2655 |
|
2023
Q2 | $819K | Buy |
+21,603
| New | +$819K | ﹤0.01% | 2732 |
|
2023
Q1 | – | Sell |
-60,137
| Closed | -$1.75M | – | 3141 |
|
2022
Q4 | $1.75M | Buy |
60,137
+5,292
| +10% | +$154K | ﹤0.01% | 2451 |
|
2022
Q3 | $1.65M | Buy |
54,845
+1,065
| +2% | +$31.9K | ﹤0.01% | 2500 |
|
2022
Q2 | $1.95M | Buy |
53,780
+319
| +0.6% | +$11.5K | ﹤0.01% | 2447 |
|
2022
Q1 | $2.41M | Hold |
53,461
| – | – | ﹤0.01% | 2417 |
|
2021
Q4 | $2.61M | Sell |
53,461
-9,218
| -15% | -$450K | ﹤0.01% | 2442 |
|
2021
Q3 | $4.06M | Buy |
62,679
+5,195
| +9% | +$337K | ﹤0.01% | 2324 |
|
2021
Q2 | $4.14M | Buy |
57,484
+3,024
| +6% | +$218K | ﹤0.01% | 2338 |
|
2021
Q1 | $4.02M | Buy |
54,460
+40,036
| +278% | +$2.95M | ﹤0.01% | 2271 |
|
2020
Q4 | $1.06M | Buy |
+14,424
| New | +$1.06M | ﹤0.01% | 2784 |
|
2015
Q3 | – | Sell |
-20,149
| Closed | -$2.9K | – | 1515 |
|
2015
Q2 | $2.9K | Buy |
20,149
+677
| +3% | +$97 | 0.02% | 666 |
|
2015
Q1 | $2.75M | Buy |
+19,472
| New | +$2.75M | 0.02% | 697 |
|